Replies to post #324878 on NorthWest Biotherapeutics Inc (NWBO)

[TiltMyBrain]

During May 2020, the Company entered into financings totaling $3.3 million (the “May Financings”). The financings were comprised of $3.1 million from the offering of 15.7 million shares of common stock and 5.6 million warrants. The common stock was offered at a price between $0.17 and $0.225 per share. The warrants have an exercise price between $0.22 and $0.23 per share and an exercise period between 1.5-2.5 years.

All of the warrants issued in these financings are suspended until November 1, 2020. In addition, as part of these agreements, the investors who have existing outstanding warrants that have not already been suspended until November 1 are suspending approximately 14.6 million existing warrants until November 1, 2020.

Looks like 14.4 and 5.6 million warrants held by investors.

The Boogy Man is not that bad!

Happy Halloween!!

[TiltMyBrain]

Nope I stand corrected: in the last 10q there is this one liner:

As of June 30, 2020, approximately 166.5 million warrants were suspended until November 1, 2020.